Authors:
MARSHALL SA
JONES RN
MURRAY PR
WASHINGTON JA
ALLEN SD
GERLACH EH
ERWIN ME
Citation: Sa. Marshall et al., IN-VITRO COMPARISON OF DU-6859A, A NOVEL FLUOROQUINOLONE, WITH OTHER QUINOLONES AND OPAL CEPHALOSPORINS TESTED AGAINST 5086 RECENT CLINICALISOLATES, Journal of antimicrobial chemotherapy, 32(6), 1993, pp. 877-884
Authors:
BALE MJ
JONES RN
MURRAY PR
WASHINGTON JA
GERLACH EH
THORNSBERRY C
HINDLER J
DOERN GV
Citation: Mj. Bale et al., QUALITY-CONTROL GUIDELINES FOR CEFDINIR, CEFEPIME, CEFETAMET, CEFMETAZOLE, CEFPODOXIME, CEFPROZIL, AND CLINAFLOXACIN (CI-960) FOR VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TESTING METHODS, Journal of clinical microbiology, 31(9), 1993, pp. 2538-2540
Authors:
KIRKLEY BA
EASLEY KA
BASILLE BA
WASHINGTON JA
Citation: Ba. Kirkley et al., CONTROLLED CLINICAL COMPARISON OF 2 LYSIS-BASED BLOOD CULTURE SYSTEMS, ISOLATOR AND SEPTI-CHEK RELEASE, FOR DETECTION OF BLOOD-STREAM INFECTIONS, Journal of clinical microbiology, 31(8), 1993, pp. 2114-2117
Authors:
WASHINGTON JA
JONES RN
GERLACH EH
MURRAY PR
ALLEN SD
KNAPP CC
Citation: Ja. Washington et al., MULTICENTER COMPARISON OF IN-VITRO ACTIVITIES OF FK-037, CEFEPIME, CEFTRIAXONE, CEFTAZIDIME, AND CEFUROXIME, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1696-1700
Authors:
SANDIN RL
HALL GS
LONGWORTH DL
WASHINGTON JA
Citation: Rl. Sandin et al., UNPREDICTABILITY OF COMMERCIALLY AVAILABLE EXOANTIGEN CULTURE CONFIRMATION TESTS IN CONFIRMING THE IDENTITY OF 5 BLASTOMYCES-DERMATITIDIS ISOLATES, American journal of clinical pathology, 99(5), 1993, pp. 542-545